Gilead Sciences Inc(GILD)

66.37

Change: 0 (0)

As of Fri 02/15/2019 03:01 AM

% Of Value

Growth

Value Per Share

:

:

:

137.87

-6.89

48.1400

Fundamentals Data

Open 72.27 Dividend 1358
Close Price 66.37 DivYield 2.42 %
High 72.62 Growth -2249000000
Low 72.12 Growth% -6.89
P/e 6.92 Volume 385860930
P/b 11.39 Market Capital 87586497900
Highest High 85.47 Lowest Low 64.12
50 Days Moving Average 73.48 50 Days Moving Average Percentage 70.80
Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Balance Sheet Table: last 5 years

Type Year1 Year2 Year3 Year4 Current Year TIM
Total liabilities 11930 11128 19238 33305 38090
Total cash 1862 2132 10128 14607 11895
Shares 1583 1695 1647 1521 1358 1326
Free Cash Flow Per Share
Free Cash Flow 2798 2914 12261 19582 15921 13397
Cap Spending -397 -191 -557 -747 -748 -608
Operating Cash Flow 3195 3105 12818 20329 16669 14005
Revenue 9702 11202 24890 32639 30390 28466
ROE% 32.30 29.74 90.32 106.64 72.16 63.92

Reports for GILD

Date Author Title Action
2016-10-13 stanko gilead is the leader of hep C drugs and 14 brand names with 1/3 of market cap in debt view

Latest Searches

Stock Close Price %of value Date